Literature DB >> 25129825

Magnetic resonance perfusion and diffusion imaging characteristics of transient bone marrow edema, avascular necrosis and subchondral insufficiency fractures of the proximal femur.

Dirk Mueller1, Christoph Schaeffeler2, Thomas Baum3, Flavia Walter4, Hans Rechl5, Ernst J Rummeny6, Klaus Woertler7.   

Abstract

PURPOSE: To evaluate magnetic resonance (MR) perfusion and diffusion imaging characteristics in patients with transient bone marrow edema (TBME), avascular necrosis (AVN), or subchondral insufficiency fractures (SIF) of the proximal femur.
MATERIALS AND METHODS: 29 patients with painful hip and bone marrow edema pattern of the proximal femur on non-contrast MR imaging were examined using diffusion-weighted and dynamic gadolinium-enhanced sequences. Apparent diffusion coefficients (ADCs) and perfusion parameters were calculated for different regions of the proximal femur. Regional distribution and differences in ADC values and perfusion parameters were evaluated.
RESULTS: Seven patients presented with TBME, 15 with AVN and seven with SIF of the proximal femur. Perfusion imaging showed significant differences for maximum enhancement values (Emax), slope (Eslope) and time to peak (TTP) between the three patient groups (p<0.05). In contrast, no significant differences for ADC values were calculated when comparing TBME, AVN, and SIF patients.
CONCLUSION: Diffusion weighted imaging of bone marrow of the proximal femur did not show significant differences between patients with TBME, AVN or SIF. In contrast, MR perfusion imaging demonstrated significant differences for the different patient groups and may as a complementary imaging technique add information to the understanding of the pathophysiology of diseases associated with bone marrow edema.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bone marrow; Femur head necrosis; Hip joint; Magnetic resonance imaging; Perfusion imaging

Mesh:

Substances:

Year:  2014        PMID: 25129825     DOI: 10.1016/j.ejrad.2014.07.017

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  8 in total

Review 1.  Is bone marrow edema syndrome a precursor of hip or knee osteonecrosis? Results of 49 patients and review of the literature.

Authors:  Tobias Geith; Ann-Cathrin Stellwag; Peter E Müller; Maximilian Reiser; Andrea Baur-Melnyk
Journal:  Diagn Interv Radiol       Date:  2020-07       Impact factor: 2.630

Review 2.  [Bone marrow edema-differential diagnosis of the femoral head necrosis].

Authors:  P Stumpp; A Roth
Journal:  Orthopade       Date:  2018-09       Impact factor: 1.087

Review 3.  The role of imaging in diagnosis and management of femoral head avascular necrosis.

Authors:  Guglielmo Manenti; Simone Altobelli; Luca Pugliese; Umberto Tarantino
Journal:  Clin Cases Miner Bone Metab       Date:  2016-04-07

Review 4.  Stress fractures: pathophysiology, clinical presentation, imaging features, and treatment options.

Authors:  George R Matcuk; Scott R Mahanty; Matthew R Skalski; Dakshesh B Patel; Eric A White; Christopher J Gottsegen
Journal:  Emerg Radiol       Date:  2016-03-22

5.  Imaging modalities in patients with slipped capital femoral epiphysis.

Authors:  T Hesper; C Zilkens; B Bittersohl; R Krauspe
Journal:  J Child Orthop       Date:  2017-04       Impact factor: 1.548

6.  Detection of avascular necrosis on routine diffusion-weighted whole body MRI in patients with multiple myeloma.

Authors:  Naeem Ahmed; Priya Sriskandarajah; Christian Burd; Angela Riddell; Kevin Boyd; Martin Kaiser; Christina Messiou
Journal:  Br J Radiol       Date:  2019-02-12       Impact factor: 3.039

7.  Osteonecrosis of the Femoral Head.

Authors:  Gary George; Joseph M Lane
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2022-05-01

Review 8.  Edema-like marrow signal intensity: a narrative review with a pictorial essay.

Authors:  Davide Maraghelli; Maria Luisa Brandi; Marco Matucci Cerinic; Anna Julie Peired; Stefano Colagrande
Journal:  Skeletal Radiol       Date:  2020-10-07       Impact factor: 2.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.